Boeravinone ECAS# 137787-00-9 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 137787-00-9 | SDF | Download SDF |
| PubChem ID | 11537197 | Appearance | Powder |
| Formula | C17H12O7 | M.Wt | 328.3 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 3,6,9,11-tetrahydroxy-10-methyl-6H-chromeno[3,4-b]chromen-12-one | ||
| SMILES | CC1=C(C=C2C(=C1O)C(=O)C3=C(O2)C(OC4=C3C=CC(=C4)O)O)O | ||
| Standard InChIKey | NCWLTPKGFNPAMP-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H12O7/c1-6-9(19)5-11-13(14(6)20)15(21)12-8-3-2-7(18)4-10(8)24-17(22)16(12)23-11/h2-5,17-20,22H,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Boeravinone E exhibits spasmolytic activity. |
Boeravinone E Dilution Calculator
Boeravinone E Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.046 mL | 15.23 mL | 30.4599 mL | 60.9199 mL | 76.1499 mL |
| 5 mM | 0.6092 mL | 3.046 mL | 6.092 mL | 12.184 mL | 15.23 mL |
| 10 mM | 0.3046 mL | 1.523 mL | 3.046 mL | 6.092 mL | 7.615 mL |
| 50 mM | 0.0609 mL | 0.3046 mL | 0.6092 mL | 1.2184 mL | 1.523 mL |
| 100 mM | 0.0305 mL | 0.1523 mL | 0.3046 mL | 0.6092 mL | 0.7615 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 12-O-Acetylrosmarinine
Catalog No.:BCN2125
CAS No.:137760-53-3
- 7-Methoxy-beta-carboline-1-propionic acid
Catalog No.:BCN2995
CAS No.:137756-13-9
- 9-Methoxycanthin-6-one-N-oxide
Catalog No.:BCN2994
CAS No.:137739-74-3
- BIM 187
Catalog No.:BCC5933
CAS No.:137734-88-4
- GR 64349
Catalog No.:BCC5800
CAS No.:137593-52-3
- Bisindolylmaleimide II
Catalog No.:BCC7868
CAS No.:137592-45-1
- Taxifolin 7-O-rhamnoside
Catalog No.:BCN6851
CAS No.:137592-12-2
- [Lys5,MeLeu9,Nle10]-NKA(4-10)
Catalog No.:BCC5994
CAS No.:137565-28-7
- VT-464 racemate
Catalog No.:BCC5399
CAS No.:1375603-36-3
- Poricoic acid B
Catalog No.:BCN8260
CAS No.:137551-39-4
- Poricoic acid A(F)
Catalog No.:BCN3741
CAS No.:137551-38-3
- 1-Benzoylpiperazine
Catalog No.:BCC8456
CAS No.:13754-38-6
- 2,3-Di(3',4'-methylenedioxybenzyl)-2-buten-4-olide
Catalog No.:BCN1576
CAS No.:137809-97-3
- Valsartan
Catalog No.:BCC5017
CAS No.:137862-53-4
- Valsartan methyl ester
Catalog No.:BCC9189
CAS No.:137863-17-3
- 6-O-Feruloylglucose
Catalog No.:BCN6195
CAS No.:137887-25-3
- ML 239
Catalog No.:BCC3987
CAS No.:1378872-36-6
- Arillatose B
Catalog No.:BCN6196
CAS No.:137941-45-8
- CBB1003
Catalog No.:BCC5524
CAS No.:1379573-88-2
- CBB1007
Catalog No.:BCC4272
CAS No.:1379573-92-8
- Dehydrotolvaptan
Catalog No.:BCC8932
CAS No.:137973-76-3
- Mozavaptan
Catalog No.:BCC5095
CAS No.:137975-06-5
- Atroscine
Catalog No.:BCN1941
CAS No.:138-12-5
- Mafenide
Catalog No.:BCC5237
CAS No.:138-39-6
A beta-secretase (BACE1)-inhibiting C-methylrotenoid induced by yeast elicitation in Abronia nana suspension cultures.[Pubmed:24557951]
Appl Biochem Biotechnol. 2014 Apr;172(7):3529-37.
Suspension cultures of Abronia nana were established to produce C-methylisoflavones. Treatment of the A. nana cultures with yeast elicitor induced Boeravinone E (1), with maximum induction at 24 h after elicitor treatment. Of the biotic and abiotic elicitors tested, yeast extract gave the strongest induction of 1. The IC50 value of 1 against beta-secretase (beta-amyloid cleaving enzyme-1) was 5.57 muM. Other proteases such as trypsin, chymotrypsin, and elastase were not inhibited by concentrations up to 1.0 mM, indicating that inhibition of beta-secretase was specific. 1 was noncompetitive in Dixon plot, and Ki value was 3.79 muM.
Isolation of new rotenoids from Boerhaavia diffusa and evaluation of their effect on intestinal motility.[Pubmed:16254824]
Planta Med. 2005 Oct;71(10):928-32.
A bioassay-guided separation of a methanolic extract obtained from the roots of Boerhaavia diffusa L. (Nyctaginaceae) allowed us to isolate five compounds belonging to the class of rotenoids: the known boeravinone D ( 1), Boeravinone E ( 2), compound 5 and two novel compounds that we have named boeravinone G ( 3) and boeravinone H ( 4). The structures of the new molecules have been determined on the basis of their HR-EI-MS, (1)H- and (13)C-NMR and 2D-NMR (HMQC, HMBC) data. All the isolated rotenoids have been evaluated for their effect on intestinal motility in vitro. Three of them (boeravinone G, Boeravinone E and compound 5) exhibited spasmolytic activity. Preliminary structure-activity relationships have been established highlighting the effect of substitutions on rings B and D.
